Provided by Tiger Fintech (Singapore) Pte. Ltd.

Exagen

6.77
-0.2900-4.11%
Pre-market: 7.090.3200+4.73%07:30 EDT
Volume:210.04K
Turnover:1.43M
Market Cap:148.00M
PE:-8.01
High:7.10
Open:7.10
Low:6.62
Close:7.06
Loading ...

Michael Mahler, Phd Joins Exagen as Chief Scientific Officer to Enhance Leadership in Autoimmune Diagnostics

THOMSON REUTERS
·
23 Jun

Press Release: Michael Mahler, PhD Joins Exagen as Chief Scientific Officer to Enhance Leadership in Autoimmune Diagnostics

Dow Jones
·
23 Jun

Exagen Registers 1.15 Million Share Sale by Investor Perceptive Credit Holdings

MT Newswires Live
·
21 Jun

BRIEF-Exagen files prospectus related to resale of up to 1.2 mln shares

Reuters
·
21 Jun

Exagen files to sell 1.15M shares of common stock for holders

TIPRANKS
·
21 Jun

Exagen Inc. Holds 2025 Annual Stockholder Meeting

TIPRANKS
·
12 Jun

Exagen Inc. Concluded Annual Stockholders Meeting with Four Proposals Voted

Reuters
·
12 Jun

Exagen Is Maintained at Overweight by Cantor Fitzgerald

Dow Jones
·
15 May

Exagen Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
13 May

Exagen Enters Underwriting Agreement for Stock Offering

TIPRANKS
·
09 May

BUZZ-U.S. STOCKS ON THE MOVE-Tapestry, Carvana, PPG Industries

Reuters
·
08 May

Exagen Prices $17.6 Million Public Offering; Shares Down

MT Newswires Live
·
08 May

BRIEF-Exagen Inc. Prices Public Offering Of Common Stock At $5.25 Per Share

Reuters
·
08 May

Exagen Inc. Prices Public Offering of Common Stock

THOMSON REUTERS
·
08 May

Exagen Inc - Expected Gross Proceeds of $17.6 Million From Offering

THOMSON REUTERS
·
08 May

BUZZ-Exagen falls after stock sale launch

Reuters
·
08 May

Exagen Inc. Announces Public Offering of Common Stock to Expand Autoimmune Testing Solutions

Reuters
·
08 May

Exagen Inc. Announces Proposed Public Offering of Common Stock

THOMSON REUTERS
·
08 May

Exagen Inc. Reports Record Revenue Amid Strategic Growth

TIPRANKS
·
06 May

William Blair Keeps Their Buy Rating on Exagen (XGN)

TIPRANKS
·
06 May